Loading…
Mindray (Shenzhen, China) announced its intention to acquire control of APT Medical (Shenzhen, China), a cardiovascular medical device company, for $927 million using its own funds via share transfer and waiver of voting rights.
Mindray announced its intention to acquire control of APT Medical (688617.SH), a Chinese cardiovascular medical device company, for 6.65 billion yuan ($927 million) through a share transfer and voting rights waiver. Mindray will become the largest and controlling shareholder with 24.61% of APT Medical's equity.